An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation-Reference-Cited by-同舟云学术

An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Published:2021-09 Issue:9 Volume:11 Page:2694-2708
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Harms Mirja,Habib Monica M.W.,Nemska Simona^ORCID,Nicolò Antonella,Gilg Andrea,Preising Nico,Sokkar Pandian^ORCID,Carmignani Sara^ORCID,Raasholm Martina,Weidinger Gilbert^ORCID,Kizilsavas Gönül,Wagner Manfred,Ständker Ludger,Abadi Ashraf H.,Jumaa Hassan,Kirchhoff Frank,Frossard Nelly^ORCID,Sanchez-Garcia Elsa,Münch Jan

Funder

Deutsche Forschungsgemeinschaft

Boehringer Ingelheim Stiftung

Baden-Württemberg Stiftung

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference59 articles.

1. CXCL12 signaling is essential for maturation of the ventricular coronary endothelial plexus and establishment of functional coronary circulation;Cavallero;Dev Cell,2015

2. The role of CXCL12 in the organ-specific process of artery formation;Ara;Blood,2005

3. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses;Salcedo;Microcirculation,2003